MedTrace Logo

Monitoring of Hemodynamics in Heart Failure Patients by Intracardiac Impedance Measurement

NCT01711281 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2015-07-15

No results posted yet for this study

Summary

Heart Failure (HF) is one of the most frequent diagnoses upon hospitalization and is a major cause of death. Cardiac resynchronization therapy (CRT) using an implantable device for synchronous bi-ventricular stimulation leads to improvement of hemodynamic parameters, physical capacity and quality of life. A continuous measurement of the left-ventricular volume would provide information about heart performance and could be used for both heart failure monitoring and optimization of CRT-therapy.

Conditions

Interventions

DEVICE

Intracardiac Impedance Measurement Algorithm (integrated in CRT-D device)

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Peter Sogaard, MD, PhD, Prof. · Aalborg University, Aalborg University Hospital

  • Klaus-Jürgen Gutleben, MD, PhD · Herz- und Diabeteszentrum NRW, Bad Oeynhausen

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-06-30

Countries

  • Denmark
  • Germany
  • Italy
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01711281 on ClinicalTrials.gov